Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 5:21 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 289–312 of 354 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Treatment Decisions Clear all

Conditions: Hiv
Interventions: Health education materials, Patient-provider decision tool; Behavioral
Lead sponsor: City University of New York; Other
Eligibility: 18 Years and older
Enrollment: 243 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 6
States / cities: Brooklyn, New York • Congers, New York • Mamaroneck, New York + 3 more

Conditions: Mental Disorders, Schizophrenia, Overweight, Obesity
Interventions: Psychosocial Weight Intervention; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: NMIBC, MIBC, Muscle Invasive Bladder Cancer (MIBC), Non Muscle Invasive Bladder Cancer
Interventions: This is a non-interventional, observational, prospective study.; Other
Lead sponsor: Bladder Cancer Advocacy Network; Other
Eligibility: 18 Years and older
Enrollment: 1,400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2032
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Advanced Cancers, Pain
Interventions: Fentanyl Nasal Spray, Hydromorphone Hydrochloride, Phone Call; Drug · Behavioral
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: Not listed
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Stage IV Colorectal Cancer
Interventions: Dignity Therapy; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Kidney Diseases, Cardiometabolic Risk Factors
Interventions: ImPart-Multi - IMproving the decisional PARTnership of Chronic Kidney Disease Dyads with concurrent metabolic disease; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: End-Stage Kidney Disease, Kidney Failure, Chronic, Kidney Transplantation
Interventions: iChoose Kidney Decision Aid; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 470 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 3
States / cities: Atlanta, Georgia • Chicago, Illinois • New York, New York

Conditions: Decision Making ,Shared, De-escalation
Interventions: Qualitative Interview or Focus group discussions; Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Rheumatoid Arthritis
Interventions: Certolizumab Pegol (CZP); Biological
Lead sponsor: UCB Pharma; Industry
Eligibility: 18 Years and older
Enrollment: 736 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 110
States / cities: Birmingham, Alabama • Huntsville, Alabama • Peoria, Arizona + 98 more

Conditions: Breast Cancer, Early Stage Estrogen Receptor (ER) Positive Breast Cancer
Interventions: BCI Assay Results; Behavioral
Lead sponsor: Yale University; Other
Eligibility: Female only
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Cancer, Brain Tumor, Solid Tumor, Leukemia, Lymphoma
Interventions: Not listed
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 13 Years and older
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Asthma in Children
Interventions: AsthmaTuner, Asthma-Guidance and Prediction System; Device · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 6 Years to 17 Years
Enrollment: 49 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Depression
Interventions: Clinical Decision Support System; Device
Lead sponsor: Aifred Health; Industry
Eligibility: 18 Years and older
Enrollment: 94 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 5
States / cities: West Haven, Connecticut • Miami, Florida • Atlanta, Georgia + 2 more

Conditions: Psychotic Disorders
Interventions: Peer-Delivered Decision Support Intervention; Behavioral
Lead sponsor: Temple University; Other
Eligibility: 18 Years to 30 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 3
States / cities: Broomall, Pennsylvania • Danville, Pennsylvania • Philadelphia, Pennsylvania

Conditions: Decision Support System, Outcome
Interventions: Routine care, AFM; Procedure · Device
Lead sponsor: Assistance Publique - Hôpitaux de Paris; Other
Eligibility: 18 Years and older
Enrollment: 2,007 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Irvine, California • Los Angeles, California

Conditions: Selective Mutism, Social Anxiety
Interventions: Fluoxetine; Drug
Lead sponsor: Michigan State University; Other
Eligibility: 5 Years to 18 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: East Lansing, Michigan

Conditions: Breast Cancer, Lung Cancer, Colorectal Cancer
Interventions: Focus groups; Behavioral
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Carcinoma, Renal Cell
Interventions: Fitbit Versa; Device
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 89 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Constipation, Constipation by Outlet Obstruction, Constipation-predominant Irritable Bowel Syndrome, Constipation - Functional
Interventions: Standard Physical Therapy Care, Aerobic and Inspiratory Muscle Training; Other
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Coral Gables, Florida

Conditions: Hiv
Interventions: HIV-ASSIST, DHHS guidelines; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: Not listed
Enrollment: 138 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Atrial Fibrillation, Patient Engagement
Interventions: Shared decision-making tool; Other
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 2
States / cities: New York, New York

Conditions: Ovarian Cancer
Interventions: Shared Medical Decision Tool, Engaging Patients in Decision Making, Literacy Spanish Language; Other · Behavioral
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Osteoporotic Fractures, Osteoporosis
Interventions: Posterior stabilization (pedicle screws); Procedure
Lead sponsor: AO Foundation, AO Spine; Other
Eligibility: 50 Years and older
Enrollment: 648 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 2
States / cities: San Francisco, California • Philadelphia, Pennsylvania

Conditions: Rheumatoid Arthritis
Interventions: US-ANSWER-2 decision aid, Control group (Online medication guide); Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Search by objective public record fields.

Assessing Perceptions and Preferences Around Long-acting Injectables (APPLI)

A System for Preference Assessment in Mental Health

Outcomes for IR and High Risk (HR) Non-muscle Invasive Bladder Cancer (NMIBC) and ctDNA-based Biomarkers for Response and Recurrence in Muscle Invasive Bladder Cancer (MIBC)

Compare Fentanyl Nasal Spray With Intravenous Opioids to Treat Severe Pain

Dignity Therapy in mCRC to Increase Peaceful Awareness & Impact Goals of Care Decision-Making

Feasibility Trial of a Stakeholder-enhanced Lay-navigator-delivered Intervention (ImPart-Multi)

iChoose Decision Kidney Aid for End-Stage Renal Disease Patients

Enhancing Shared Decision-Making in Metastatic Breast Cancer (Qualitative Study)

A Comparison of Two Assessment Tools in Predicting Treatment Success of Cimzia in Rheumatoid Arthritis Subjects

Assessment of the Decision-making Impact of the Breast Cancer Index in Recommending Extended Adjuvant Endocrine Therapy for Patients With Early Stage ER-positive Breast Cancer

Medical Treatment Decision Making Using Adaptive Conjoint Analysis

A Study of Remote Asthma Management Using an Integrated Artificial Intelligence-assisted EHR Dashboard and Mobile Device Compared With Usual Asthma Care to Treat 6-17 Year Old Patients

Artificial Intelligence in Depression - Medication Enhancement

Facilitating Engagement in Evidence-Based Treatment for Early Psychosis

Assisted Fluid Management (AFM) System and Postoperative Outcome After High-risk Abdominal Surgery

Evaluating the Results of Physician and Parent Decisions to Treat Selective Mutism With Fluoxetine

Examining Patient Preferences About the IBM Watson Oncology Clinical Decision Support System

Mobile Intervention - Physical Activity in Cancer Treatment

The Impact of Aerobic Interval and Inspiratory Muscle Training On Patient Reported Outcome Scores In Individuals With Chronic Constipation

Antiretroviral Therapy Selection: Comparing HIV Clinical Guidelines With HIV-ASSIST, an Online Decision-support Tool

Data-driven SDM to Reduce Symptom Burden in AF

Spanish Decision Tool for Ovarian Cancer Maintenance Therapy

The Osteoporotic Fracture Classification-based Scoring System for Treatment Decision in Thoracolumbar Osteoporotic Fractures

Supporting Patient Care With Electronic Resources in the United States